Clinical Trials Directory

Trials / Completed

CompletedNCT00495898

A Study of Diabetic Patients With De Novo Native Coronary Artery Lesions

A German Multicenter, Randomized, Controlled, Open-Label Study of the Cypher Sirolimus-Eluting Stent in the Treatment of Diabetic Patients With De Novo Native Coronary Artery Lesions

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
200 (actual)
Sponsor
Cordis US Corp. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The main objective of this study is to assess the safety and effectiveness of the CYPHER sirolimus-eluting stent in maintaining minimum lumen diameter in de novo native coronary artery lesions as compared to the uncoated Bx VELOCITY balloon-expandable stent in patients with manifest diabetes mellitus. Both stents are mounted on the Raptorâ Rapid Exchange Stent Delivery System.

Detailed description

This is a multicenter (19 sites), prospective, 2 arm randomized study designed to assess the safety and effectiveness of the CYPHER sirolimus-eluting stent as compared to the uncoated Bx VELOCITY balloon-expandable stent in patients with manifest diabetes mellitus. Patients with de novo native coronary artery lesions \<= 42 mm in length and \>=2.5mm and \<=3.5mm in diameter (by visual estimate) will be included in the study. A total of 190 patients will be entered and randomly allocated to the CYPHERTM sirolimus-eluting stent or the uncoated Bx VELOCITY balloon-expandable stent at a 1:1 ratio. Patients will be followed for 12 months post-procedure, with all patients having a repeat angiography at 8 months (± 1 month). It is anticipated the total duration of the study will be 18 months: 6 months to complete patient enrollment and 12 months for follow up.

Conditions

Interventions

TypeNameDescription
DEVICECYPHER sirolimus-eluting stentdrug-eluting stent
DEVICEuncoated Bx VELOCITY balloon-expandable stentbare metal stent

Timeline

Start date
2002-11-01
Primary completion
2005-05-01
Completion
2009-11-01
First posted
2007-07-03
Last updated
2009-12-03

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT00495898. Inclusion in this directory is not an endorsement.